Published in J Immunol on February 01, 1969
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med (1970) 4.41
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66
Human immunoglobulin specificity after group B arbovirus infections. Infect Immun (1972) 1.29
Circulating immune complexes in serum from patients with dengue haemorrhagic fever. Clin Exp Immunol (1979) 1.27
The ultrastructure of vascular lesions in equine viral arteritis. Am J Pathol (1970) 1.14
Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment. Microbiol Mol Biol Rev (2015) 0.96
Could peak proteinuria determine whether patient with dengue fever develop dengue hemorrhagic/dengue shock syndrome?--a prospective cohort study. BMC Infect Dis (2011) 0.84
Pathogenetic mechanisms in dengue haemorrhagic fever: report of an international collaborative study. Bull World Health Organ (1973) 0.83
In vitro studies of the normal human B lymphocyte receptors for preformed soluble dengue antigen-antibody complexes. Clin Exp Immunol (1980) 0.78
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Flaviviridae. Intervirology (1985) 3.06
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57
Bunyaviridae. Intervirology (1980) 2.53
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32
Togaviridae. Intervirology (1985) 1.96
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79
Radioimmune precipitation of group A arboviruses. J Immunol (1972) 1.71
Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69
Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69
An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68
Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67
Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66
The proteins of Japanese encephalitis virus. Virology (1971) 1.63
An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med (1967) 1.61
Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58
Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58
Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51
Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47
MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44
Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44
Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis (1977) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis (1977) 1.38
Partial purification and characterization of a dengue virus soluble complement-fixing antigen. J Immunol (1970) 1.37
Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol (1971) 1.36
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33
Antigenic components of group A arbovirus virions. J Virol (1973) 1.30
Dengue virions and antigens in brain and serum of infected mice. J Virol (1970) 1.30
Human immunoglobulin specificity after group B arbovirus infections. Infect Immun (1972) 1.29
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun (1981) 1.28
Dengue-2 vaccine: viremia and immune responses in rhesus monkeys. Infect Immun (1980) 1.27
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. J Infect Dis (1983) 1.27
Cytological localization of Dengue-2 antigens: an immunological study with ultrastructural correlation. Infect Immun (1973) 1.26
Recovery of dengue viruses from patients during epidemics in Puerto Rico and East Pakistan. Am J Trop Med Hyg (1966) 1.25
RNA fingerprinting as a method for distinguishing dengue 1 virus strains. Am J Trop Med Hyg (1983) 1.25
Togaviridae. Intervirology (1978) 1.24
Comparison of dengue-2 and dengue-3 virus strains by neutralization tests and identification of a subtype of dengue-3. Am J Trop Med Hyg (1972) 1.23
Assay of arbovirus neutralizing antibody by micro methods. Trans R Soc Trop Med Hyg (1969) 1.21
Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization. Infect Immun (1972) 1.21
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J Infect Dis (1984) 1.20
Enteritis and gastritis in young asymptomatic Pakistani men. Am J Dig Dis (1966) 1.19
Swine influenza A at Fort Dix, New Jersey (January-February 1976). II. Transmission and morbidity in units with cases. J Infect Dis (1977) 1.17
Detection of dengue cell-surface antigens by peroxidase-labeled antibodies and immune cytolysis. Infect Immun (1974) 1.16
Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am J Trop Med Hyg (1987) 1.13
The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab (2000) 1.12
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. Am J Trop Med Hyg (1984) 1.11
Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, Aedes aegypti. Am J Trop Med Hyg (1982) 1.10
Recurrence of epidemic dengue hemorrhagic fever in an insular setting. Am J Trop Med Hyg (1969) 1.09
An insular outbreak of dengue hemorrhagic fever. I. Epidemiologic observations. Am J Trop Med Hyg (1968) 1.08
The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J (2000) 1.05
Complement fixation blocking activity of anti-dengue IgM antibody. J Immunol (1972) 1.05
Cache Valley virus in the Del Mar Va Peninsula. I. Virologic and serologic evidence of infection. Am J Trop Med Hyg (1970) 1.02
Ecology of arboviruses in a Maryland freshwater swamp. 3. Vertebrate hosts. Am J Epidemiol (1972) 1.01
Bunyaviruses and bunyaviridae. Intervirology (1974) 1.01
Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses. Virology (1970) 0.99
Membrane-bound proteins of Japanese encephalitis virus-infected chick embryo cells. Virology (1972) 0.98
Specificity and sensitivity of radioimmunoassay for hepatitis B antigen. Appl Microbiol (1974) 0.97
Mosquito vectors of dengue viruses in South Vietnam. Am J Trop Med Hyg (1969) 0.97
Dimethyl sulfoxide enhancement of phlebotomus fever virus plaque formation. Am J Trop Med Hyg (1979) 0.96
Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers. Infect Immun (1972) 0.93
Chikungunya disease. Am J Trop Med Hyg (1968) 0.92
Family with hepatitis-associated antigen. Spectrum of liver pathology. JAMA (1971) 0.92
Potential of polymer microencapsulation technology for vaccine innovation. Vaccine (1994) 0.92
Field trials of methisazone as a prophylactic agent against smallpox. Am J Epidemiol (1971) 0.90
RNA polymerase in group B arbovirus (dengue-2) infected cells. Brief report. Arch Gesamte Virusforsch (1973) 0.89
Hepatitis B antigen and antibody. Occurrence in families of asymptomatic HB AG carriers. JAMA (1974) 0.89
Observations on fevers of unknown origin in the Rephblic of Vietnam. Mil Med (1969) 0.88
Comparison of the virion polypeptides of group B arboviruses. Infect Immun (1972) 0.87
Method for extracting viral hemagglutination-inhibiting antibodies from the nonspecific inhibitors of serum. Appl Microbiol (1970) 0.86
Influence of cell type and virus upon virus-specific immune cytolysis. Infect Immun (1975) 0.86
Virion and soluble antigens of japanese encephalitis virus. Infect Immun (1975) 0.86
Adenovirus vaccines in military recruit populations: a cost-benefit analysis. J Infect Dis (1973) 0.85
Protein synthesis in Japanese encephalitis virus-infected cells. Virology (1973) 0.85
Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities. Biochemistry (2001) 0.85
Kaeng Khoi virus from naturally infected bedbugs (cimicidae) and immature free-tailed bats. Bull World Health Organ (1976) 0.84
Recovery of dengue-2 virus from Aedes aegypti in Colombia. Am J Trop Med Hyg (1973) 0.84
An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines. Am J Epidemiol (1972) 0.83
The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion. J Biol Chem (2001) 0.82
Expression of a TGF-beta superfamily protein, macrophage inhibitory cytokine-1, in the yeast Pichia pastoris. Gene (2000) 0.82
Catino D: Investigations on acute febrile illness in American servicemen in the Mekong Delta of Vietnam. Mil Med (1969) 0.81
Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipients. Am J Trop Med Hyg (1982) 0.81
Temperature-sensitive events during the replication of the attenuated S-1 clone of dengue type 2 virus. Infect Immun (1983) 0.80
Separation of dengue strains on the basis of a nonstructural antigen. Am J Trop Med Hyg (1971) 0.78
Viral polypeptide composition of Japanese encephalitis virus-infected cell membranes. Arch Virol (1975) 0.78